Wednesday, October 09, 2024 6:30:33 AM
Hi JTFM, did you ever share your key findings with the analysts following ANI ? I guess some would be interested to know and inclined to ask more direct questions during the quarterly calls. Tezruly would be a good example of that. Q3 call is in less than a month...
These were the ones present in the last quartely call:
Les Sulewski - Truist Securities
Gary Nachman - Raymond James & Associates
Vamil Divan - Guggenheim Securities
Oren Livnat - H.C. Wainwright & Co.
Tim Chiang - Capital One
Also sending a note to IR (or Nikhil, board members, ...) could be an idea. Even if they don't reply, it shows that some people are closely monitoring what their are doing (and not saying).
My biggest fear is that there's a plan in place that will leave the small investors out of the big reward. Have seen that 15 years ago in one of my first investments when I knew little about investing (forgot the name of the pharma company). They literally managed to sell the company way below its actual value by assigning special plans to management.
These were the ones present in the last quartely call:
Les Sulewski - Truist Securities
Gary Nachman - Raymond James & Associates
Vamil Divan - Guggenheim Securities
Oren Livnat - H.C. Wainwright & Co.
Tim Chiang - Capital One
Also sending a note to IR (or Nikhil, board members, ...) could be an idea. Even if they don't reply, it shows that some people are closely monitoring what their are doing (and not saying).
My biggest fear is that there's a plan in place that will leave the small investors out of the big reward. Have seen that 15 years ago in one of my first investments when I knew little about investing (forgot the name of the pharma company). They literally managed to sell the company way below its actual value by assigning special plans to management.
Recent ANIP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 08:40:36 PM
- ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules • IH Market News • 04/13/2026 03:12:39 PM
- ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules • GlobeNewswire Inc. • 04/13/2026 10:50:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:14:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:13:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:12:05 PM
- ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet • GlobeNewswire Inc. • 04/08/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:21:22 PM
- ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology • GlobeNewswire Inc. • 04/07/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:09:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:09:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:07:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:06:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:04:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:46:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 10:22:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:46:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:45:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:01:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 12:05:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:59:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:59:32 PM
